Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Assets (2016 - 2025)

Angiodynamics (ANGO) has disclosed Assets for 15 consecutive years, with $269.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets changed N/A year-over-year to $269.7 million, compared with a TTM value of $269.7 million through Nov 2025, changed N/A, and an annual FY2025 reading of $280.1 million, down 11.81% over the prior year.
  • Assets was $269.7 million for Q4 2025 at Angiodynamics, up from $265.6 million in the prior quarter.
  • Across five years, Assets topped out at $582.2 million in Q1 2021 and bottomed at $265.6 million in Q3 2025.
  • Average Assets over 5 years is $467.8 million, with a median of $542.8 million recorded in 2023.
  • The sharpest move saw Assets rose 0.74% in 2022, then tumbled 40.36% in 2024.
  • Year by year, Assets stood at $554.1 million in 2021, then increased by 0.74% to $558.2 million in 2022, then fell by 10.5% to $499.6 million in 2023, then crashed by 36.41% to $317.7 million in 2024, then decreased by 15.11% to $269.7 million in 2025.
  • Business Quant data shows Assets for ANGO at $269.7 million in Q4 2025, $265.6 million in Q3 2025, and $280.1 million in Q2 2025.